RUBNOV; Shai

Patent Applications and Registrations

Patent applications and USPTO patent grants for RUBNOV; Shai.The latest application filed is for "process for preparing microparticles containing glatiramer acetate".

Company Profile

0.25.32

RUBNOV; Shai - Tel Aviv IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process For Preparing Microparticles Containing Glatiramer Acetate App 20210299057 - BLEICH KIMELMAN; Nadav ; et al.	2021-09-30
Depot Systems Comprising Glatiramer Acetate App 20210283209 - MAROM; Ehud ; et al.	2021-09-16
Extended Release Dosage Forms Of Pregabalin App 20210260006 - SELA; Yoram ; et al.	2021-08-26
Extended release dosage forms of pregabalin Grant 11,026,908 - Sela , et al. June 8, 2	2021-06-08
Extended Release Dosage Forms Of Pregabalin App 20190298675 - SELA; Yoram ; et al.	2019-10-03
Process and intermediates for the preparation of perampanel Grant 10,111,867 - Marom , et al. October 30, 2	2018-10-30
Amorphous form of apremilast Grant 9,994,522 - Rubnov , et al. June 12, 2	2018-06-12
Process And Intermediates For The Preparation Of Perampanel App 20180008584 - MAROM; Ehud ; et al.	2018-01-11
Amorphous Form Of Apremilast App 20170174626 - RUBNOV; Shai ; et al.	2017-06-22
Intermediate compounds and process for the preparation of efinaconazole Grant 9,617,241 - Gopin , et al. April 11, 2	2017-04-11
Intermediate Compounds And Process For The Preparation Of Efinaconazole App 20160355500 - GOPIN; Anna ; et al.	2016-12-08
Amorphous form of dolutegravir Grant 9,206,197 - Marom , et al. December 8, 2	2015-12-08
Random pentapolymer for treatment of autoimmune diseases Grant 9,200,114 - Marom , et al. December 1, 2	2015-12-01
Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium Grant 9,102,592 - Marom , et al. August 11, 2	2015-08-11
Polymorphs of perampanel Grant 9,096,574 - Marom , et al. August 4, 2	2015-08-04
Co-crystals of dapagliflozin Grant 9,006,188 - Marom , et al. April 14, 2	2015-04-14
Intermediate compounds and process for the preparation of lurasidone and salts thereof Grant 8,981,095 - Marom , et al. March 17, 2	2015-03-17
Process and intermediates for the preparation of abiraterone acetate Grant 8,975,244 - Marom , et al. March 10, 2	2015-03-10
Intermediate Compounds And Processes For The Preparation Of Quinoline Derivatives Such As Laquinimod Sodium App 20150051419 - MAROM; Ehud ; et al.	2015-02-19
Polymorphs Of Perampanel App 20140371273 - Marom; Ehud ; et al.	2014-12-18
Amorphous Form Of Dolutegravir App 20140350004 - Marom; Ehud ; et al.	2014-11-27
Co-crystals Of Dapagliflozin App 20140343010 - MAROM; Ehud ; et al.	2014-11-20
Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium Grant 8,865,742 - Marom , et al. October 21, 2	2014-10-21
Process for the preparation of alogliptin Grant 8,841,447 - Marom , et al. September 23, 2	2014-09-23
Process And Intermediates For The Preparation Of Substituted 2-arylthiazole Carboxylic Acids App 20140228417 - Mizhiritskii; Michael ; et al.	2014-08-14
Depot systems comprising glatiramer or a pharmacologically acceptable salt thereof Grant 8,796,226 - Marom , et al. August 5, 2	2014-08-05
Processes for the preparation of deferasirox, and deferasirox polymorphs Grant 8,772,503 - Mizhiritskii , et al. July 8, 2	2014-07-08
Intermediate Compounds And Process For The Preparation Of Lurasidone And Salts Thereof App 20140179922 - Marom; Ehud ; et al.	2014-06-26
Process And Intermediates For The Preparation Of Abiraterone Acetate App 20140155363 - MAROM; Ehud ; et al.	2014-06-05
Intermediate compounds and process for the preparation of fingolimod Grant 8,735,627 - Marom , et al. May 27, 2	2014-05-27
Intermediate Compounds And Processes For The Preparation Of Quinoline Derivatives Such As Laquinimod Sodium App 20130245065 - Marom; Ehud ; et al.	2013-09-19
Polymorphs Of Febuxostat App 20130225830 - Marom; Ehud ; et al.	2013-08-29
Intermediate Compounds And Process For The Preparation Of Fingolimod App 20130217899 - Marom; Ehud ; et al.	2013-08-22
Random Pentapolymer For Treatment Of Autoimmune Diseases App 20130156725 - MAROM; Ehud ; et al.	2013-06-20
Polymorphs Of Alogliptin Benzoate App 20130059872 - Marom; Ehud ; et al.	2013-03-07
Preparation Of Benzofurans And Use Thereof As Synthetic Intermediates App 20130046103 - Marom; Ehud ; et al.	2013-02-21
Depot systems comprising glatiramer or pharmacologically acceptable salt thereof Grant 8,377,885 - Marom , et al. February 19, 2	2013-02-19
Processes For The Preparation Of Deferasirox, And Deferasirox Polymorphs App 20120245361 - Mizhiritskii; Michael ; et al.	2012-09-27
Depot Systems Comprising Glatiramer Or Pharmacologically Acceptable Salt Thereof App 20120164229 - MAROM; Ehud ; et al.	2012-06-28
Process For The Preparation Of Alogliptin App 20120029000 - Marom; Ehud ; et al.	2012-02-02
Depot Systems Comprising Glatiramer Or A Pharmacologically Acceptable Salt Thereof App 20120015891 - Marom; Ehud ; et al.	2012-01-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.